Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-07-30 4:01 pm Purchase | 2021-07-20 | 13D | Erasca, Inc. ERAS | Cormorant Asset Management, LP | 10,505,553 8.830% | 10,505,553 (New Position) | Filing History |
| 2021-07-12 4:19 pm Purchase | 2021-07-02 | 13G | Aerovate Therapeutics, Inc. AVTE | Cormorant Asset Management, LP | 58,020 8.320% | 58,020 (New Position) | Filing History |
| 2021-07-09 4:06 pm Purchase | 2021-06-29 | 13G | Elevation Oncology, Inc. ELEV | Cormorant Asset Management, LP | 1,983,168 8.690% | 1,983,168 (New Position) | Filing History |
| 2021-07-08 4:02 pm Purchase | 2021-06-28 | 13G | Monte Rosa Therapeutics, Inc. GLUE | Cormorant Asset Management, LP | 3,193,974 7.180% | 3,193,974 (New Position) | Filing History |
| 2021-07-02 4:12 pm Purchase | 2021-06-22 | 13G | Ambrx Biopharma Inc. AMAM | Cormorant Asset Management, LP | 17,404,702 6.600% | 17,404,702 (New Position) | Filing History |
| 2021-05-19 4:09 pm Purchase | 2021-05-18 | 13G | Revolution Medicines, Inc. RVMD | Cormorant Asset Management, LP | 3,675,000 5.000% | 1,179,934 (+47.29%) | Filing History |
| 2021-04-09 4:07 pm Purchase | 2021-03-30 | 13G | Constellation Pharmaceuticals, Inc. CNST | Cormorant Asset Management, LP | 5,114,844 9.200% | 5,114,844 (New Position) | Filing History |
| 2021-03-26 4:06 pm Purchase | 2021-03-16 | 13G | Prometheus Biosciences, Inc. RXDX | Cormorant Asset Management, LP | 2,098,022 5.410% | 2,098,022 (New Position) | Filing |
| 2021-03-26 4:05 pm Purchase | 2021-03-16 | 13G | Longboard Pharmaceuticals, Inc. LBPH | Cormorant Asset Management, LP | 1,339,631 9.990% | 1,339,631 (New Position) | Filing History |
| 2021-02-16 3:34 pm Sale | 2020-12-31 | 13G | Tarsus Pharmaceuticals, Inc. TARS | Cormorant Asset Management, LP | 1,714,269 8.450% | -249,999 (-12.73%) | Filing History |
| 2021-02-16 3:33 pm Sale | 2020-12-31 | 13G | Atea Pharmaceuticals, Inc. AVIR | Cormorant Asset Management, LP | 6,411,355 7.760% | -475,000 (-6.90%) | Filing History |
| 2021-02-16 3:32 pm Sale | 2020-12-31 | 13G | Galecto, Inc. GLTO | Cormorant Asset Management, LP | 86,029 8.510% | -5,220 (-5.72%) | Filing History |
| 2021-02-16 3:24 pm Sale | 2020-12-31 | 13G | Olema Pharmaceuticals, Inc. OLMA | Cormorant Asset Management, LP | 3,195,544 7.960% | -75,000 (-2.29%) | Filing History |
| 2021-02-16 3:16 pm Unchanged | 2020-12-31 | 13G | BioAtla, Inc. BCAB | Cormorant Asset Management, LP | 2,292,060 7.120% | 0 (Unchanged) | Filing History |
| 2021-02-16 3:15 pm Sale | 2021-02-16 | 13G | Stoke Therapeutics, Inc. STOK | Cormorant Asset Management, LP | 1,437,807 3.970% | -350,856 (-19.62%) | Filing History |
| 2021-02-16 3:14 pm Sale | 2020-12-31 | 13G | Cabaletta Bio, Inc. CABA | Cormorant Asset Management, LP | 1,904,424 7.920% | -214,709 (-10.13%) | Filing History |
| 2021-02-16 3:13 pm Sale | 2020-12-31 | 13G | PRINCIPIA BIOPHARMA INC PRNB | Cormorant Asset Management, LP | 0 0.000% | -1,990,922 (Position Closed) | Filing History |
| 2021-02-16 3:12 pm Sale | 2020-12-31 | 13G | Turning Point Therapeutics, Inc. TPTX | Cormorant Asset Management, LP | 2,392,297 4.960% | -1,004,353 (-29.57%) | Filing History |
| 2021-02-16 3:11 pm Sale | 2020-12-31 | 13G | Constellation Pharmaceuticals, Inc. CNST | Cormorant Asset Management, LP | 0 0.000% | -2,300,000 (Position Closed) | Filing History |
| 2021-02-16 3:10 pm Sale | 2020-12-31 | 13G | Avidity Biosciences, Inc. RNA | Cormorant Asset Management, LP | 2,464,547 6.570% | -49,998 (-1.99%) | Filing History |